Work

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw428

Authors: R.L. Ferris, J.L. Geiger, S. Trivedi, N.C. Schmitt, D.E. Heron, J.T. Johnson, S. Kim, U. Duvvuri, D.A. Clump, J.E. Bauman, J.P. Ohr, W.E. Gooding, A. Argiris

Institutions: UPMC Hillman Cancer Center, University of Pittsburgh, National Institutes of Health, Johns Hopkins University, National Institute on Deafness and Other Communication Disorders, Thomas Jefferson University, Hygeia Hospital

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cancer Institute, University of Pittsburgh, National Cancer Institute, National Institute of Dental and Craniofacial Research

Awards: G34221693, G5023133972, G7243726612, G741073515, G948547148

OpenAlex ID: W2531150348

FWCI: 4.081

Cites: 23

Cited by: 37

Related to: 10